The LISI Group continues to grow, with cumulative revenue up +9.1% to €1.44 billion in the first nine months of 2025 compared to 2024

•  LISI AEROSPACE: driving the Group's growth with sustained revenue growth of nearly 20% compared to 2024 in the third quarter

•  LISI AUTOMOTIVE: stable third-quarter revenue compared to 2024

•  LISI MEDICAL: gradual recovery of activity in the United States

Consolidated revenue for the first nine months of the year amounted to €1,443.2 million, up +9.1% compared to the same period in 2024, and takes into account the following factors:

•  an average negative currency impact of €20.1 million (1.4% of revenue), mainly resulting from the weakening of the average US dollar exchange rate against the euro;

•  a scope effect of -€8.6 million (0.6% of revenue) related to the sale of LISI AUTOMOTIVE Nomel.

For the third quarter, growth stood at +10.7% compared to the same period last year, with export sales remaining strong (72% of revenue in the third quarter).

Revenue growth, adjusted for currency fluctuations and the exit of LISI AUTOMOTIVE Nomel from the scope of consolidation on December 31, 2024, was +11.3% for the first nine months of the year and +14.8% for the third quarter.

OUTLOOK

The aerospace development plan is the Group's main growth driver, with favorable long-term visibility. Persistent uncertainty in the global automotive market could marginally slow the pace of improvement in overall performance.

In an uncertain geopolitical and macroeconomic environment (currency parities), the LISI Group reaffirms its confidence in achieving its 2025 objectives: a third consecutive year of improvement in key indicators, including current operating income, and the maintenance of positive free cash flow.